Investor · ATLANTA, GA

Ss Hotel Credit Opportunity Fund, LLC

Open Ss in the network graph →

Filings

16

SEC Form D

Connections

62

co-filers

Capital

$96.7M

across filings

Active

Jun 2011

to Aug 2017

Most-connected co-filers (62)

Mathew M. Crosswy · ATLANTA, GA16 shared Robert M. Woomer · ATLANTA, GA16 shared Gregory M. Friedman · ATLANTA, GA16 shared Alec S. Machiels · Crestwood, KY10 shared Storm Venture Associates V, L.L.C · MENLO PARK, CA7 shared Stephanie S. O'Brien · Newton, MA6 shared David Dworsky · Gardena, CA6 shared Dominic A. Bassani · Crestone, CO6 shared Cedric J. Francois · Crestwood, KY5 shared Pascal Deschatelets · Crestwood, KY5 shared Mary F. Hinz · Santa Cruz, CA5 shared Manuel N. Calderon · San Juan, Puerto Rico4 shared A. S. Dunlop · Bethesda, MD4 shared Jean-Sebastien R. Blanchette · Vancouver, British Columbia, Canada4 shared Mitul M. Patel · ATLANTA, GA4 shared Francisco Uriarte · Guaynabo, Puerto Rico4 shared Francisco N. Martorell · San Juan, Puerto Rico4 shared Jatin M. Desai · ATLANTA, GA4 shared Ryan R. Selwood · Halifax, Z44 shared Hubert R. Marleau · Vancouver, British Columbia, Canada4 shared Nicholas R. Zelenczuk · Halifax, Z44 shared Anna Stylianides · Vancouver, British Columbia, Canada4 shared Paul T. Worcester · Kansas City, MO4 shared Michael Marks · Menlo Park, CA4 shared

Recent filings (16)

Apellis Pharmaceuticals, Inc.Aug 2017 · 17 co-filers$60.1M Apellis Pharmaceuticals, Inc.Feb 2016 · 30 co-filers$47.1M Apellis Pharmaceuticals, Inc.Jan 2016 · 27 co-filers$32.1M Apellis Pharmaceuticals, Inc.Jun 2015 · 12 co-filers$17.7M Revon Systems, LLCMar 2015 · 11 co-filers$4.0M Stonehill Strategic Hotel Credit Opportunity QP Fund, L.P.Mar 2015 · 15 co-filers$75.0M Stonehill Strategic Hotel Credit Opportunity Fund, L.P.Mar 2015 · 18 co-filers$75.0M Apellis Pharmaceuticals, Inc.Dec 2014 · 12 co-filers$21.5M Stonehill Strategic Hotel Credit Opportunity Fund, L.P.Oct 2014 · 18 co-filers$75.0M Stonehill Strategic Hotel Credit Opportunity QP Fund, L.P.Oct 2014 · 15 co-filers$75.0M Apellis Pharmaceuticals, Inc.Aug 2014 · 9 co-filers$24.0M Revon Systems, LLCDec 2013 · 3 co-filers$3.3M Apellis Pharmaceuticals, Inc.Aug 2013 · 9 co-filers$8.0M Apellis Pharmaceuticals, Inc.Jul 2012 · 14 co-filers$3.0M Apellis Pharmaceuticals, Inc.Jun 2011 · 15 co-filers$4.2M Apellis Pharmaceuticals, Inc.Jun 2011 · 15 co-filers$4.2M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Ss in the interactive graph →